| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/01/2013 | CN102302553B Extraction method of key components of Chinese magnoliavine fruit medicament |
| 05/01/2013 | CN102258547B Hazel leaf flavone extract and medicinal composition thereof |
| 05/01/2013 | CN102234259B Sphaelactone derivatives, their pharmaceutical compositions, preparation method thereof and application thereof |
| 05/01/2013 | CN102228599B Chinese medicinal preparation for treating tumor |
| 05/01/2013 | CN102204936B Preparation method of total triterpene extract from poria cocos |
| 05/01/2013 | CN102190718B Recombined litopenaeus setiferus protein SF-P9, preparation method and application thereof |
| 05/01/2013 | CN102145071B Medicinal compositions for inhibiting growth of stem cells |
| 05/01/2013 | CN102100710B Fermentation processing method for ginseng and research and development of related products thereof |
| 05/01/2013 | CN102068509B Method for preparing pulsatilla chinensis (Bunge) Regel active ingredient, method for preparing preparation of pulsatilla chinensis (Bunge) Regel active ingredient and application of pulsatilla chinensis (Bunge) Regel active ingredient in preparation of antineoplastic medicament |
| 05/01/2013 | CN102058535B Novel folate receptor targeted liposome |
| 05/01/2013 | CN101979566B Sulpho-oligodeoxynucleotide with immunostimulation activities and application thereof |
| 05/01/2013 | CN101863786B Water-soluble shikonin naphthazarin oxygen nucleus alkyl derivative and preparation and application methods thereof |
| 05/01/2013 | CN101861307B Certain substituted amides, method of making, and method of use thereof |
| 05/01/2013 | CN101843606B Application of emodin as sensitizer and multidrug-resistance reversal agent of acute leukemia chemotherapy medicament |
| 05/01/2013 | CN101824065B Fatty-acid monoester compound of ginsenoside secondary glycoside Rh1 and preparation method thereof |
| 05/01/2013 | CN101723935B 1,5-diaryl-substituted 2,4-dienone derivative as well as preparation method and application thereof |
| 05/01/2013 | CN101511860B SMAC peptidomimetics useful as IAP inhibitors |
| 05/01/2013 | CN101479255B C-MET protein kinase inhibitors for the treatment of proliferative disorders |
| 04/30/2013 | US8431695 Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases |
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431583 Use of purine derivatives for the manufacture of a medicament |
| 04/30/2013 | US8431545 Copolymer including uncharged hydrophilic block and cationic polyamino acid block having hydrophobic group in part of side chains, and use thereof |
| 04/30/2013 | US8431530 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 04/30/2013 | US8431522 Methods of inhibiting tumor cell proliferation |
| 04/30/2013 | US8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/30/2013 | US8431124 Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP) |
| 04/30/2013 | CA2595834C Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 04/30/2013 | CA2486303C Histone deacetylase inhibitors based on alpha-ketoepoxide compounds |
| 04/30/2013 | CA2453522C Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 04/30/2013 | CA2452491C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 04/30/2013 | CA2435664C Ncc2705-the genome of a bifidobacterium |
| 04/30/2013 | CA2417495C Methods for treating cell proliferative disorders and viral infections |
| 04/30/2013 | CA2412612C Eg-vegf nucleic acids and polypeptides and methods of use |
| 04/30/2013 | CA2403964C Compositions and methods for dendritic cell-based immunotherapy |
| 04/25/2013 | WO2013059784A1 Antigen presenting cancer vaccine |
| 04/25/2013 | WO2013059778A2 Antigen presenting cancer vaccine with gamma interferon |
| 04/25/2013 | WO2013059772A1 Enzyme inhibitor for cancer treatment |
| 04/25/2013 | WO2013059753A1 Therapeutic combination for the treatment of cancer |
| 04/25/2013 | WO2013059738A2 Use of inhibitors of bruton's tyrosine kinase (btk) |
| 04/25/2013 | WO2013059593A1 Anti-cd22 chimeric antigen receptors |
| 04/25/2013 | WO2013059582A2 Small molecule inhibitors of histone deacteylases |
| 04/25/2013 | WO2013059548A1 Compositions and methods for treating cancer using jak2 inhibitor |
| 04/25/2013 | WO2013059471A1 Compositions and methods for treating leukemia |
| 04/25/2013 | WO2013059437A1 Inhibitors of arginase and their therapeutic applications |
| 04/25/2013 | WO2013059433A2 Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer |
| 04/25/2013 | WO2013059320A1 Treatment of cancers with mutant npm1 with mek inhibitors |
| 04/25/2013 | WO2013059295A2 Polymeric depots for localization of an agent to biological sites |
| 04/25/2013 | WO2013059232A1 Methods and compositions for the management of cancer using 2-dg and an igf-ir inhibitor |
| 04/25/2013 | WO2013059215A1 Substituted biaryl alkyl amides |
| 04/25/2013 | WO2013059194A1 Meldrum 's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors |
| 04/25/2013 | WO2013058751A1 Cellulose derivatives for enhancing bioavailability of flavonoids |
| 04/25/2013 | WO2013058691A1 Method for inhibition of deubiquitinating activity |
| 04/25/2013 | WO2013058681A2 Substituted phenoxyacetic acids and esters and amides thereof, comprising a 2,6-dioxo-2,3,6,7-tetrahydro-1н-purine-8-yl fragment and constituting а2a adenosine receptor antagonists, and the use thereof |
| 04/25/2013 | WO2013058613A2 2-hydroxyarylamide derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating cancer containing same as active ingredient |
| 04/25/2013 | WO2013058482A2 Multi-functional nucleic acid-based anti-cancer drug capable of targeting and therapy, method for preparing same and anti-cancer composition comprising same |
| 04/25/2013 | WO2013058361A1 Crystals of androgen receptor antagonist compound |
| 04/25/2013 | WO2013058344A1 Method for predicting effect of plk1 inhibitor |
| 04/25/2013 | WO2013058294A1 Therapeutic agent for pancreatic cancer and/or biliary tract cancer |
| 04/25/2013 | WO2013057711A1 Quinazoline derivatives as pi3k modulators |
| 04/25/2013 | WO2013057487A1 Phytocannabinoids for use in the treatment of breast cancer |
| 04/25/2013 | WO2013057469A1 Pharmaceutical antiretroviral compositions |
| 04/25/2013 | WO2013057322A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/25/2013 | WO2013057222A2 Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones |
| 04/25/2013 | WO2013057148A1 ACID ADDITION SALTS OF 5α-HYDROXY-6β-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3β-OL |
| 04/25/2013 | WO2013056716A1 Pd-l1 based immunotherapy |
| 04/25/2013 | WO2013056684A2 Thiazole derivative as dhodh inhibitor and use thereof |
| 04/25/2013 | WO2013056670A1 Small interference rnas, uses thereof and method for inhibiting the expression of plk1 gene |
| 04/25/2013 | WO2013056657A1 Activity-enhanced l-asparaginase variant |
| 04/25/2013 | WO2013056547A1 Synthesis of a group of hydantoin derivatives and use thereof |
| 04/25/2013 | WO2013056510A1 Use for deoxynucleoside/nucleoside combination in preparation of tumor medicament |
| 04/25/2013 | WO2013056453A1 Preparation method and application of injection for needleless injection |
| 04/25/2013 | WO2013056372A1 Peptide compounds derived from melanotransferrin and uses thereof |
| 04/25/2013 | WO2013056352A1 Antibodies and antibody fragments targeting sirp-alpha and their use in treating hematologic cancers |
| 04/25/2013 | WO2013056309A1 Novel plant defensins and use in the treatment of proliferative diseases |
| 04/25/2013 | WO2013056308A1 Novel forms of plant defensins |
| 04/25/2013 | WO2013033636A3 Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same |
| 04/25/2013 | WO2013030218A4 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 04/25/2013 | WO2013028334A3 Use of small molecules in methods for purification of biomolecules |
| 04/25/2013 | WO2013025882A3 Tricyclic compounds as anticancer agents |
| 04/25/2013 | WO2013025446A3 Anti-fzd10 monoclonal antibodies and methods for their use |
| 04/25/2013 | WO2013022280A3 N1-cyclic amine-n2-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 04/25/2013 | WO2013022279A3 N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 04/25/2013 | WO2013022278A3 N1-cyclic amine-n5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 04/25/2013 | WO2013019923A3 Methods for detecting progenitor cells and uses thereof |
| 04/25/2013 | WO2013019093A3 Novel aniline derivatives and use thereof |
| 04/25/2013 | WO2013016452A3 Cancer treatment using bmp inhibitor |
| 04/25/2013 | WO2013013038A3 Doping agents and polymeric compositions thereof for controlled drug delivery |
| 04/25/2013 | WO2013006864A3 Treating cancer with hsp90 inhibitory compounds |
| 04/25/2013 | WO2013001372A3 Methods and compositions for inhibition of activation of regulatory t cells |
| 04/25/2013 | WO2012177624A3 Focused radiation for augmenting immune-based therapies against neoplasms |
| 04/25/2013 | WO2012177603A3 Metalloenzyme inhibitor compounds |
| 04/25/2013 | WO2012174487A3 Bromodomain inhibitors and uses thereof |
| 04/25/2013 | WO2012170929A3 Monoclonal antibody and antigens for diagnosing and treating lung disease and injury |
| 04/25/2013 | WO2012162629A3 Popcorn shape gold nanoparticle for targeted diagnosis, photothermal treatment and in-situ monitoring therapy response for cancer and multiple drug resistance bacteria |
| 04/25/2013 | WO2012021512A8 Erythrocyte-binding therapeutics |
| 04/25/2013 | WO2011163512A3 Cancer therapy |
| 04/25/2013 | WO2011116954A3 Prophylaxis of colorectal and gastrointestinal cancer |
| 04/25/2013 | US20130102898 Liposome including elastin-like polypeptides and use thereof |
| 04/25/2013 | US20130102757 Methods for selective targeting |
| 04/25/2013 | US20130102657 Anti-angiogenic compositions and methods of use |